S100A8 and metabolic dysfunction-associated steatotic liver disease: When compared with the individuals in the healthy group, the expression of CXCR2, PTPRC, CCR2, MNDA, NCF2, S100A9, S100A8, and S100A12 was also upregulated in NAFLD patients.